TAVALISSE Trademark

Trademark Overview

On Tuesday, April 11, 2017, a trademark application was filed for TAVALISSE with the United States Patent and Trademark Office. The USPTO has given the TAVALISSE trademark a serial number of 87407547. The federal status of this trademark filing is REGISTERED as of Tuesday, July 30, 2019. This trademark is owned by Rigel Pharmaceuticals, Inc.. The TAVALISSE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of immune system diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; anti-inflammatory pharmaceutical preparations; pharmaceutical preparations for the treatment of hematological conditions, diseases and disorders
tavalisse

General Information

Serial Number87407547
Word MarkTAVALISSE
Filing DateTuesday, April 11, 2017
Status700 - REGISTERED
Status DateTuesday, July 30, 2019
Registration Number5822266
Registration DateTuesday, July 30, 2019
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 29, 2017

Trademark Statements

Description of MarkThe mark consists of a circular design comprised of concentric circles in the colors gray, green and orange. The word "TAVALISSE" is to the right of the circular design in stylized green font. The color white is not claimed as a feature of the mark and represents background only.
Goods and ServicesPharmaceutical preparations for the treatment of immune system diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; anti-inflammatory pharmaceutical preparations; pharmaceutical preparations for the treatment of hematological conditions, diseases and disorders
Indication of Colors claimedThe color(s) gray, green and orange is/are claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 19, 2017
Primary Code005
First Use Anywhere DateMonday, April 30, 2018
First Use In Commerce DateMonday, April 30, 2018

Trademark Owner History

Party NameRigel Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameRigel Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94080
Party NameRigel Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94080

Trademark Events

Event DateEvent Description
Monday, July 3, 2017ASSIGNED TO EXAMINER
Friday, July 7, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 14, 2017NEW APPLICATION ENTERED
Wednesday, April 19, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 20, 2017NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, July 7, 2017EXAMINERS AMENDMENT -WRITTEN
Friday, July 7, 2017EXAMINER'S AMENDMENT ENTERED
Friday, July 7, 2017EXAMINERS AMENDMENT E-MAILED
Friday, July 7, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, October 24, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, October 24, 2018SOU TEAS EXTENSION RECEIVED
Wednesday, August 9, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 29, 2017PUBLISHED FOR OPPOSITION
Tuesday, August 29, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 24, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 24, 2018SOU TEAS EXTENSION RECEIVED
Tuesday, April 24, 2018SOU EXTENSION 1 FILED
Tuesday, April 24, 2018SOU EXTENSION 1 GRANTED
Thursday, April 26, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 24, 2018SOU EXTENSION 2 FILED
Wednesday, October 24, 2018SOU EXTENSION 2 GRANTED
Friday, October 26, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 24, 2019TEAS STATEMENT OF USE RECEIVED
Wednesday, April 24, 2019USE AMENDMENT FILED
Tuesday, May 7, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, May 7, 2019STATEMENT OF USE PROCESSING COMPLETE
Monday, May 13, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 26, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, June 27, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, March 17, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 17, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 17, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 17, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 8, 2019ASSIGNED TO EXAMINER
Tuesday, July 30, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, March 17, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, February 3, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, February 3, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, February 3, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, February 3, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, February 3, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, August 14, 2024TEAS SECTION 8 & 15 RECEIVED
Tuesday, July 30, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

tavalisse pharmaceutical preparations disorders diseases treatment inflammatory conditions hematological anti system